V.F. Corporation (VFC)
(Delayed Data from NYSE)
$12.34 USD
+0.37 (3.09%)
Updated May 24, 2024 04:00 PM ET
After-Market: $12.33 -0.01 (-0.08%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
Price, Consensus and EPS Surprise
VFC 12.34 +0.37(3.09%)
Will VFC be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for VFC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VFC
V.F. Corp (VFC) Stock Stumbles on Q4 Loss & Revenue Miss
V.F. (VFC) Reports Q4 Earnings: What Key Metrics Have to Say
VFC: What are Zacks experts saying now?
Zacks Private Portfolio Services
V.F. (VFC) Reports Q4 Loss, Misses Revenue Estimates
Here's How V.F. Corp (VFC) Looks Just Ahead of Q4 Earnings
Seeking Clues to V.F. (VFC) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Other News for VFC
Wall Street's Top 10 Stock Calls This Week - Saturday, May 25
Buy/Sell: Wall Street's top 10 stock calls this week
V.F. Corporation Is Speculative With Real Risks Of Permanent Capital Loss
VF Corp. stock outperforms competitors on strong trading day
Market Today: Novo Nordisk Faces FDA Setback, Cathie Wood's Market Warning, and More